A Double-blind, Randomized Controlled Trial of Ciplukan (Physalis angulata Linn) Extract on Skin Fibrosis, Inflammatory, Immunology, and Fibrosis Biomarkers in Scleroderma Patients

• Main Authors: Sumartini Dewi (Author), Harry Isbagio (Author), Erni Hernawati Purwaningsih (Author), Nyoman Kertia (Author), Rianto Setiabudy (Author), Siti Setiati (Author)
• Format: Book
• Published: Interna Publishing, 2019-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: scleroderma is an autoimmune disease characterized by organ fibrosis, resistant to standard treatment. It is suspected the addition of Physalis angulata Linn. (Ciplukan) extract as adjuvant therapy can improve the scleroderma skin fibrosis. The aim at this study is to evaluate the effect...